258 related articles for article (PubMed ID: 15835269)
1. Dysferlin interacts with affixin (beta-parvin) at the sarcolemma.
Matsuda C; Kameyama K; Tagawa K; Ogawa M; Suzuki A; Yamaji S; Okamoto H; Nishino I; Hayashi YK
J Neuropathol Exp Neurol; 2005 Apr; 64(4):334-40. PubMed ID: 15835269
[TBL] [Abstract][Full Text] [Related]
2. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.
Matsuda C; Hayashi YK; Ogawa M; Aoki M; Murayama K; Nishino I; Nonaka I; Arahata K; Brown RH
Hum Mol Genet; 2001 Aug; 10(17):1761-6. PubMed ID: 11532985
[TBL] [Abstract][Full Text] [Related]
3. Defective membrane repair in dysferlin-deficient muscular dystrophy.
Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
[TBL] [Abstract][Full Text] [Related]
4. Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle.
Klinge L; Harris J; Sewry C; Charlton R; Anderson L; Laval S; Chiu YH; Hornsey M; Straub V; Barresi R; Lochmüller H; Bushby K
Muscle Nerve; 2010 Feb; 41(2):166-73. PubMed ID: 20082313
[TBL] [Abstract][Full Text] [Related]
5. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.
Piccolo F; Moore SA; Ford GC; Campbell KP
Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547
[TBL] [Abstract][Full Text] [Related]
6. Dysferlin mediates membrane tubulation and links T-tubule biogenesis to muscular dystrophy.
Hofhuis J; Bersch K; Büssenschütt R; Drzymalski M; Liebetanz D; Nikolaev VO; Wagner S; Maier LS; Gärtner J; Klinge L; Thoms S
J Cell Sci; 2017 Mar; 130(5):841-852. PubMed ID: 28104817
[TBL] [Abstract][Full Text] [Related]
7. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).
Weiler T; Bashir R; Anderson LV; Davison K; Moss JA; Britton S; Nylen E; Keers S; Vafiadaki E; Greenberg CR; Bushby CR; Wrogemann K
Hum Mol Genet; 1999 May; 8(5):871-7. PubMed ID: 10196377
[TBL] [Abstract][Full Text] [Related]
8. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
[TBL] [Abstract][Full Text] [Related]
9. Dysferlin and the plasma membrane repair in muscular dystrophy.
Bansal D; Campbell KP
Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
[TBL] [Abstract][Full Text] [Related]
10. Intracellular localization of dysferlin and its association with the dihydropyridine receptor.
Ampong BN; Imamura M; Matsumiya T; Yoshida M; Takeda S
Acta Myol; 2005 Oct; 24(2):134-44. PubMed ID: 16550931
[TBL] [Abstract][Full Text] [Related]
11. Dysferlin protein analysis in limb-girdle muscular dystrophies.
Vainzof M; Anderson LV; McNally EM; Davis DB; Faulkner G; Valle G; Moreira ES; Pavanello RC; Passos-Bueno MR; Zatz M
J Mol Neurosci; 2001 Aug; 17(1):71-80. PubMed ID: 11665864
[TBL] [Abstract][Full Text] [Related]
12. From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis.
Klinge L; Laval S; Keers S; Haldane F; Straub V; Barresi R; Bushby K
FASEB J; 2007 Jun; 21(8):1768-76. PubMed ID: 17363620
[TBL] [Abstract][Full Text] [Related]
13. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
[TBL] [Abstract][Full Text] [Related]
14. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing.
Lennon NJ; Kho A; Bacskai BJ; Perlmutter SL; Hyman BT; Brown RH
J Biol Chem; 2003 Dec; 278(50):50466-73. PubMed ID: 14506282
[TBL] [Abstract][Full Text] [Related]
15. Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.
Millay DP; Maillet M; Roche JA; Sargent MA; McNally EM; Bloch RJ; Molkentin JD
Am J Pathol; 2009 Nov; 175(5):1817-23. PubMed ID: 19834057
[TBL] [Abstract][Full Text] [Related]
16. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration.
Huang Y; Laval SH; van Remoortere A; Baudier J; Benaud C; Anderson LV; Straub V; Deelder A; Frants RR; den Dunnen JT; Bushby K; van der Maarel SM
FASEB J; 2007 Mar; 21(3):732-42. PubMed ID: 17185750
[TBL] [Abstract][Full Text] [Related]
17. Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.
Gushchina LV; Bhattacharya S; McElhanon KE; Choi JH; Manring H; Beck EX; Alloush J; Weisleder N
Mol Ther; 2017 Oct; 25(10):2360-2371. PubMed ID: 28750735
[TBL] [Abstract][Full Text] [Related]
18. Dysferlin, annexin A1, and mitsugumin 53 are upregulated in muscular dystrophy and localize to longitudinal tubules of the T-system with stretch.
Waddell LB; Lemckert FA; Zheng XF; Tran J; Evesson FJ; Hawkes JM; Lek A; Street NE; Lin P; Clarke NF; Landstrom AP; Ackerman MJ; Weisleder N; Ma J; North KN; Cooper ST
J Neuropathol Exp Neurol; 2011 Apr; 70(4):302-13. PubMed ID: 21412170
[TBL] [Abstract][Full Text] [Related]
19. The C2 domains of dysferlin: roles in membrane localization, Ca
Muriel J; Lukyanenko V; Kwiatkowski T; Bhattacharya S; Garman D; Weisleder N; Bloch RJ
J Physiol; 2022 Apr; 600(8):1953-1968. PubMed ID: 35156706
[TBL] [Abstract][Full Text] [Related]
20. Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin.
Cai C; Weisleder N; Ko JK; Komazaki S; Sunada Y; Nishi M; Takeshima H; Ma J
J Biol Chem; 2009 Jun; 284(23):15894-902. PubMed ID: 19380584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]